Impact of Cardiovascular Outcome Trial (CVOT) Data on EU5 Access for New Type 2 Diabetes Drugs
Abstract
Authors
L DiModica E O'Connor
L DiModica E O'Connor
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now